This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Best Practice Show

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website?

Legal Notice

BEST PRACTICE BIRMINGHAM IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR BEST PRACTICE BIRMINGHAM CAN BE FOUND HERE.

Co-Located Events

Best Practice Programme 2023

Subpage Hero

     

Loading

Prostate Cancer: Men at risk, the medical pathway and impact of health inequalities

12 Oct 2023
GP Clinical Theatre 2
Prostate Cancer: Men at risk, the medical pathway and impact of health inequalities
In 2018, prostate cancer diagnoses in the UK rose to  57,192, exceeding those of breast, lung and bowel cancers. Around 20% of diagnoses are at stage 4 (metastatic) and a similar percentage at stage 3 (locally advanced). The COVID pandemic has made matters worse because there were 14,000 fewer diagnoses of prostate cancer than expected between January 2018 and December 2020. An awareness raising campaign was effective leading to 4,000 extra diagnoses compared to pre-pandemic norms in 2019, up to end of Nov 2022. We need to be alert to men at risk. A man is two and half times more likely to get prostate cancer if his father or brother has been diagnosed with it, compared to a man with no family history and black men are more likely to get prostate cancer than other men. In the UK, about 1 in 4 Black men will get prostate cancer at some point in their lives. As a result, prostate cancer is included in the Primary Care Network (PCN) Direct Enhanced Service Specification 2022/23. The plan is to develop and implement a strategy to increase the proactive and opportunistic assessment of patients for a potential cancer diagnosis, targeting: Men aged 50 -70, black men aged 45 -70, and those with a family history of prostate cancer aged 45-70. The medical pathway has changed dramatically over the last few years and is much safer for the patients. Health inequality has an adverse impact on both the diagnosis and treatment efficacy. Appropriate use of the PSA blood test. Identifying men at risk Advances in diagnosis and treatment The adverse impact of health inequalities

Newsletter Sign Up